The effects of selenium on tumor growth in epithelial ovarian carcinoma
Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in...
Saved in:
Published in | Journal of gynecologic oncology Vol. 23; no. 3; pp. 190 - 196 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Society of Gynecologic Oncology and Colposcopy
01.07.2012
대한부인종양학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2005-0380 2005-0399 2005-0399 |
DOI | 10.3802/jgo.2012.23.3.190 |
Cover
Abstract | Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model.
Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice.
The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone.
Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy. |
---|---|
AbstractList | Objective: Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model.
Methods: Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice.
Results: The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone.
Conclusion: Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy. KCI Citation Count: 12 Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model. Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice. The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone. Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy. Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model.OBJECTIVEEpidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting effect in ovarian cancer cells and an orthotopic animal model.Cell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice.METHODSCell growth in selenium-treated cells was determined in human ovarian cancer cells, A2780, HeyA8, and SKOV3ip1 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. Animal experiment of selenium with paclitaxel was performed using SKOV3ip1 cells in nude mice to evaluate their inhibiting effect for tumor growth. In addition, another animal experiment of paclitaxel with or without selenium was performed to assess the effect of survival and food intake in mice.The in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone.RESULTSThe in vitro growth of selenium-treated cells was significantly decreased dose-dependently in A2780, HeyA8, and SKOV3ip1 cells. Therapy experiment in mice was started 1 week after injection of the SKOV3ip1 cells. Treatment with selenium (1.5 mg/kg, 3 times/week) and paclitaxel injection showed no addictive effect of the inhibition of tumor growth. However, combination of selenium and paclitaxel showed the slightly increased food intake compared with paclitaxel alone.Although selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy.CONCLUSIONAlthough selenium has growth-inhibiting effect in ovarian carcinoma cells in vitro, there is no additive effect on tumor growth in mice treated with combination of paclitaxel and selenium. However, food intake is slightly higher in selenium-treated mice during chemotherapy. |
Author | Park, Jin Sun Lee, Jeong-Won Cho, Young Jae Bae, Duk-Soo Choi, Jung-Joo Ryu, Ji Yoon Jeon, Hye-Kyung Park, Young Ae Kim, Byoung-Gie |
AuthorAffiliation | Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Jin Sun surname: Park fullname: Park, Jin Sun organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 2 givenname: Ji Yoon surname: Ryu fullname: Ryu, Ji Yoon organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 3 givenname: Hye-Kyung surname: Jeon fullname: Jeon, Hye-Kyung organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 4 givenname: Young Jae surname: Cho fullname: Cho, Young Jae organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 5 givenname: Young Ae surname: Park fullname: Park, Young Ae organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 6 givenname: Jung-Joo surname: Choi fullname: Choi, Jung-Joo organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 7 givenname: Jeong-Won surname: Lee fullname: Lee, Jeong-Won organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 8 givenname: Byoung-Gie surname: Kim fullname: Kim, Byoung-Gie organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 9 givenname: Duk-Soo surname: Bae fullname: Bae, Duk-Soo organization: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22808362$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001681468$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqFkUFP3DAQha0KVGDpD-il8rGXTcd27MSXSgi1gIRUqVrOluOd7BoSO7UTEP--2S6FtodyGkt-z9-85xNyEGJAQt4zKEQN_NPtJhYcGC-4KETBNLwhxxxALkFoffB8ruGInOR8C6AqqPlbcsR5DbVQ_JhcrLZIsW3RjZnGlmbsMPippzHQcepjopsUH8Yt9YHi4Mctdt52NN7b5G2gzibnQ-ztKTlsbZfx3dNckJuvX1bnl8vrbxdX52fXS1cKPi5RgCxrJZtKthaRV4rbslLYyBIbxXijta51A3Jez62VrNaqtU3Jag1MlXYtFuTj_t2QWnPnvInW_5qbaO6SOfu-ujKiVCWDWcr30ikM9vHBdp0Zku9tejQMzK5AMxdodgUaLowwc4Gz6fPeNExNj2uHYUz2xbij_X0T_HZm3xshtAQmXxYcUvwxYR5N77PDrrMB45RnNK-gZHwOuCAf_mQ9Q37_ziyo9gKXYs4JW-P8aEcfd2jf_TcG-8f5evSfPxe0Xg |
CitedBy_id | crossref_primary_10_1016_j_matlet_2019_126590 crossref_primary_10_1021_acsnano_6b03835 crossref_primary_10_3802_jgo_2013_24_1_96 crossref_primary_10_3389_fbioe_2023_1252816 crossref_primary_10_1039_c3mt00002h crossref_primary_10_3390_ijms24031918 crossref_primary_10_1007_s11356_015_5960_y crossref_primary_10_3892_ijo_2015_2968 crossref_primary_10_18632_oncotarget_8619 crossref_primary_10_1016_j_jnutbio_2014_09_013 crossref_primary_10_3802_jgo_2013_24_1_97 crossref_primary_10_1016_j_cbi_2014_12_016 |
Cites_doi | 10.1200/JCO.2006.07.9970 10.1016/S0163-7258(98)00014-X 10.1016/j.tiv.2009.07.012 10.1093/jnci/92.24.2018 10.1016/j.mehy.2006.01.058 10.1007/BF02785304 10.1158/1535-7163.MCT-06-0400 10.1016/j.ygyno.2003.12.013 10.1089/ars.2007.1528 10.1016/j.colsurfb.2008.07.010 10.1093/jnci/87.7.497 10.1158/1535-7163.877.3.7 10.1007/s002800000127 10.1158/0008-5472.CAN-05-2216 10.1016/j.ijrobp.2008.07.005 10.1016/j.bcp.2003.09.021 10.1016/S1535-6108(04)00002-9 10.1158/1078-0432.CCR-03-0268 10.1093/carcin/20.9.1657 10.1097/01.ju.0000092859.16817.8e 10.1038/sj.bjc.6601974 10.1038/sj.ejcn.1600902 10.1002/jcb.20755 10.1016/S0022-5347(05)65500-0 10.1001/jama.1996.03540240035027 10.1038/emm.2004.22 10.1158/1078-0432.CCR-08-2966 10.1093/jnci/djh125 10.1079/BJN20031015 10.1093/jnci/djp231 10.1093/ajcn/79.1.80 10.1093/jnci/90.16.1219 |
ContentType | Journal Article |
Copyright | Copyright © 2012. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology 2012 |
Copyright_xml | – notice: Copyright © 2012. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology 2012 |
DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY ACYCR |
DOI | 10.3802/jgo.2012.23.3.190 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2005-0399 |
EndPage | 196 |
ExternalDocumentID | oai_kci_go_kr_ARTI_346410 10.3802/jgo.2012.23.3.190 PMC3395015 22808362 10_3802_jgo_2012_23_3_190 |
Genre | Journal Article |
GroupedDBID | 29K 2WC 5-W 53G 5GY 8JR 8XY 9ZL AAKDD AAYXX ABDBF ACUHS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION D-I DIK DU5 E3Z EBD EF. F5P GROUPED_DOAJ HYE HZB OK1 RPM M~E NPM 7X8 5PM ADTOC UNPAY ACYCR |
ID | FETCH-LOGICAL-c432t-e3054865b75faee2762a476eb54eb612b99989b05083cd657d6fab41890164ad3 |
IEDL.DBID | UNPAY |
ISSN | 2005-0380 2005-0399 |
IngestDate | Tue Nov 21 21:47:11 EST 2023 Tue Aug 19 20:45:59 EDT 2025 Thu Aug 21 13:51:22 EDT 2025 Wed Oct 01 13:32:06 EDT 2025 Thu Jan 02 22:10:16 EST 2025 Tue Jul 01 02:37:27 EDT 2025 Thu Apr 24 23:00:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Sodium selenite Cell survival Ovarian carcinoma Tumor growth |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c432t-e3054865b75faee2762a476eb54eb612b99989b05083cd657d6fab41890164ad3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both authors contributed equally. G704-001660.2012.23.3.013 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=http://synapse.koreamed.org/Synapse/Data/PDFData/1114JGO/jgo-23-190.pdf |
PMID | 22808362 |
PQID | 1027041208 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_346410 unpaywall_primary_10_3802_jgo_2012_23_3_190 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3395015 proquest_miscellaneous_1027041208 pubmed_primary_22808362 crossref_citationtrail_10_3802_jgo_2012_23_3_190 crossref_primary_10_3802_jgo_2012_23_3_190 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-07-01 |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 07 year: 2012 text: 2012-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of gynecologic oncology |
PublicationTitleAlternate | J Gynecol Oncol |
PublicationYear | 2012 |
Publisher | Korean Society of Gynecologic Oncology and Colposcopy 대한부인종양학회 |
Publisher_xml | – name: Korean Society of Gynecologic Oncology and Colposcopy – name: 대한부인종양학회 |
References | Kralova (10.3802/jgo.2012.23.3.190_ref27) 2009; 23 Clark (10.3802/jgo.2012.23.3.190_ref3) 1996; 276 Li (10.3802/jgo.2012.23.3.190_ref9) 2004; 96 Combs (10.3802/jgo.2012.23.3.190_ref23) 2004; 91 Yoshizawa (10.3802/jgo.2012.23.3.190_ref11) 1998; 90 Lee (10.3802/jgo.2012.23.3.190_ref19) 2009; 15 Jonsson-Videsater (10.3802/jgo.2012.23.3.190_ref26) 2004; 67 Ozols (10.3802/jgo.2012.23.3.190_ref2) 2004; 5 Lee (10.3802/jgo.2012.23.3.190_ref20) 2009; 101 Caffrey (10.3802/jgo.2012.23.3.190_ref21) 2000; 46 Sieja (10.3802/jgo.2012.23.3.190_ref35) 2004; 93 Zhao (10.3802/jgo.2012.23.3.190_ref30) 2006; 5 Mannisto (10.3802/jgo.2012.23.3.190_ref4) 2000; 54 Helzlsouer (10.3802/jgo.2012.23.3.190_ref8) 2000; 92 Zhong (10.3802/jgo.2012.23.3.190_ref28) 2001; 61 Garland (10.3802/jgo.2012.23.3.190_ref5) 1995; 87 Kim (10.3802/jgo.2012.23.3.190_ref18) 2004; 36 Landen (10.3802/jgo.2012.23.3.190_ref1) 2008; 26 Han (10.3802/jgo.2012.23.3.190_ref25) 2007; 40 Chen (10.3802/jgo.2012.23.3.190_ref15) 2008; 67 Hu (10.3802/jgo.2012.23.3.190_ref34) 1997; 56 Whanger (10.3802/jgo.2012.23.3.190_ref24) 2004; 91 Cao (10.3802/jgo.2012.23.3.190_ref31) 2004; 10 Combs (10.3802/jgo.2012.23.3.190_ref22) 1998; 79 Papp (10.3802/jgo.2012.23.3.190_ref12) 2007; 9 Wei (10.3802/jgo.2012.23.3.190_ref6) 2004; 79 Ganther (10.3802/jgo.2012.23.3.190_ref13) 1999; 20 Bhattacharyya (10.3802/jgo.2012.23.3.190_ref33) 2008; 72 Jiang (10.3802/jgo.2012.23.3.190_ref17) 2004; 3 Dong (10.3802/jgo.2012.23.3.190_ref16) 2006; 98 Drake (10.3802/jgo.2012.23.3.190_ref14) 2006; 67 Zhao (10.3802/jgo.2012.23.3.190_ref29) 2006; 66 Corcoran (10.3802/jgo.2012.23.3.190_ref32) 2004; 171 Nomura (10.3802/jgo.2012.23.3.190_ref10) 2000; 9 Brooks (10.3802/jgo.2012.23.3.190_ref7) 2001; 166 11585738 - Cancer Res. 2001 Oct 1;61(19):7071-8 14684401 - Am J Clin Nutr. 2004 Jan;79(1):80-5 19351748 - Clin Cancer Res. 2009 Apr 15;15(8):2695-702 18805679 - Colloids Surf B Biointerfaces. 2008 Nov 15;67(1):26-31 15252149 - Mol Cancer Ther. 2004 Jul;3(7):877-84 14749123 - Cancer Cell. 2004 Jan;5(1):19-24 14713851 - J Urol. 2004 Feb;171(2 Pt 1):907-10 16574336 - Med Hypotheses. 2006;67(2):318-22 10694779 - Eur J Clin Nutr. 2000 Feb;54(2):98-103 10469608 - Carcinogenesis. 1999 Sep;20(9):1657-66 15037203 - Biochem Pharmacol. 2004 Feb 1;67(3):513-22 15099940 - Gynecol Oncol. 2004 May;93(2):320-7 7707436 - J Natl Cancer Inst. 1995 Apr 5;87(7):497-505 19641174 - J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205 14748935 - Br J Nutr. 2004 Jan;91(1):11-28 19602434 - Toxicol In Vitro. 2009 Dec;23(8):1497-503 18760546 - Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):935-40 11696701 - J Urol. 2001 Dec;166(6):2034-8 9197929 - Biol Trace Elem Res. 1997 Mar;56(3):331-41 17172431 - Mol Cancer Ther. 2006 Dec;5(12):3275-84 15150444 - Exp Mol Med. 2004 Apr 30;36(2):157-64 18195328 - J Clin Oncol. 2008 Feb 20;26(6):995-1005 11121464 - J Natl Cancer Inst. 2000 Dec 20;92(24):2018-23 16552729 - J Cell Biochem. 2006 Aug 15;98(6):1495-506 15126606 - J Natl Cancer Inst. 2004 May 5;96(9):696-703 10912582 - Cancer Chemother Pharmacol. 2000;46(1):74-8 17394769 - J Biochem Mol Biol. 2007 Mar 31;40(2):196-204 16489034 - Cancer Res. 2006 Feb 15;66(4):2296-304 15073137 - Clin Cancer Res. 2004 Apr 1;10(7):2561-9 9719083 - J Natl Cancer Inst. 1998 Aug 19;90(16):1219-24 11008904 - Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):883-7 9776375 - Pharmacol Ther. 1998 Sep;79(3):179-92 8971064 - JAMA. 1996 Dec 25;276(24):1957-63 15213714 - Br J Cancer. 2004 Jul 19;91(2):195-9 17508906 - Antioxid Redox Signal. 2007 Jul;9(7):775-806 |
References_xml | – volume: 26 start-page: 995 year: 2008 ident: 10.3802/jgo.2012.23.3.190_ref1 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.07.9970 – volume: 9 start-page: 883 year: 2000 ident: 10.3802/jgo.2012.23.3.190_ref10 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 79 start-page: 179 year: 1998 ident: 10.3802/jgo.2012.23.3.190_ref22 publication-title: Pharmacol Ther doi: 10.1016/S0163-7258(98)00014-X – volume: 23 start-page: 1497 year: 2009 ident: 10.3802/jgo.2012.23.3.190_ref27 publication-title: Toxicol In Vitro doi: 10.1016/j.tiv.2009.07.012 – volume: 92 start-page: 2018 year: 2000 ident: 10.3802/jgo.2012.23.3.190_ref8 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.24.2018 – volume: 67 start-page: 318 year: 2006 ident: 10.3802/jgo.2012.23.3.190_ref14 publication-title: Med Hypotheses doi: 10.1016/j.mehy.2006.01.058 – volume: 56 start-page: 331 year: 1997 ident: 10.3802/jgo.2012.23.3.190_ref34 publication-title: Biol Trace Elem Res doi: 10.1007/BF02785304 – volume: 5 start-page: 3275 year: 2006 ident: 10.3802/jgo.2012.23.3.190_ref30 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-06-0400 – volume: 93 start-page: 320 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref35 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2003.12.013 – volume: 9 start-page: 775 year: 2007 ident: 10.3802/jgo.2012.23.3.190_ref12 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2007.1528 – volume: 67 start-page: 26 year: 2008 ident: 10.3802/jgo.2012.23.3.190_ref15 publication-title: Colloids Surf B Biointerfaces doi: 10.1016/j.colsurfb.2008.07.010 – volume: 87 start-page: 497 year: 1995 ident: 10.3802/jgo.2012.23.3.190_ref5 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/87.7.497 – volume: 3 start-page: 877 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref17 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.877.3.7 – volume: 46 start-page: 74 year: 2000 ident: 10.3802/jgo.2012.23.3.190_ref21 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s002800000127 – volume: 66 start-page: 2296 year: 2006 ident: 10.3802/jgo.2012.23.3.190_ref29 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2216 – volume: 72 start-page: 935 year: 2008 ident: 10.3802/jgo.2012.23.3.190_ref33 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.07.005 – volume: 67 start-page: 513 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref26 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2003.09.021 – volume: 5 start-page: 19 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref2 publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00002-9 – volume: 10 start-page: 2561 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref31 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-03-0268 – volume: 20 start-page: 1657 year: 1999 ident: 10.3802/jgo.2012.23.3.190_ref13 publication-title: Carcinogenesis doi: 10.1093/carcin/20.9.1657 – volume: 61 start-page: 7071 year: 2001 ident: 10.3802/jgo.2012.23.3.190_ref28 publication-title: Cancer Res – volume: 171 start-page: 907 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref32 publication-title: J Urol doi: 10.1097/01.ju.0000092859.16817.8e – volume: 91 start-page: 195 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref23 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601974 – volume: 54 start-page: 98 year: 2000 ident: 10.3802/jgo.2012.23.3.190_ref4 publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1600902 – volume: 98 start-page: 1495 year: 2006 ident: 10.3802/jgo.2012.23.3.190_ref16 publication-title: J Cell Biochem doi: 10.1002/jcb.20755 – volume: 166 start-page: 2034 year: 2001 ident: 10.3802/jgo.2012.23.3.190_ref7 publication-title: J Urol doi: 10.1016/S0022-5347(05)65500-0 – volume: 276 start-page: 1957 year: 1996 ident: 10.3802/jgo.2012.23.3.190_ref3 publication-title: JAMA doi: 10.1001/jama.1996.03540240035027 – volume: 36 start-page: 157 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref18 publication-title: Exp Mol Med doi: 10.1038/emm.2004.22 – volume: 15 start-page: 2695 year: 2009 ident: 10.3802/jgo.2012.23.3.190_ref19 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-2966 – volume: 96 start-page: 696 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref9 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djh125 – volume: 91 start-page: 11 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref24 publication-title: Br J Nutr doi: 10.1079/BJN20031015 – volume: 101 start-page: 1193 year: 2009 ident: 10.3802/jgo.2012.23.3.190_ref20 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djp231 – volume: 40 start-page: 196 year: 2007 ident: 10.3802/jgo.2012.23.3.190_ref25 publication-title: J Biochem Mol Biol – volume: 79 start-page: 80 year: 2004 ident: 10.3802/jgo.2012.23.3.190_ref6 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/79.1.80 – volume: 90 start-page: 1219 year: 1998 ident: 10.3802/jgo.2012.23.3.190_ref11 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/90.16.1219 – reference: 18805679 - Colloids Surf B Biointerfaces. 2008 Nov 15;67(1):26-31 – reference: 7707436 - J Natl Cancer Inst. 1995 Apr 5;87(7):497-505 – reference: 17508906 - Antioxid Redox Signal. 2007 Jul;9(7):775-806 – reference: 9776375 - Pharmacol Ther. 1998 Sep;79(3):179-92 – reference: 15252149 - Mol Cancer Ther. 2004 Jul;3(7):877-84 – reference: 14749123 - Cancer Cell. 2004 Jan;5(1):19-24 – reference: 14684401 - Am J Clin Nutr. 2004 Jan;79(1):80-5 – reference: 9719083 - J Natl Cancer Inst. 1998 Aug 19;90(16):1219-24 – reference: 15126606 - J Natl Cancer Inst. 2004 May 5;96(9):696-703 – reference: 18195328 - J Clin Oncol. 2008 Feb 20;26(6):995-1005 – reference: 11696701 - J Urol. 2001 Dec;166(6):2034-8 – reference: 11585738 - Cancer Res. 2001 Oct 1;61(19):7071-8 – reference: 10469608 - Carcinogenesis. 1999 Sep;20(9):1657-66 – reference: 11008904 - Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):883-7 – reference: 10694779 - Eur J Clin Nutr. 2000 Feb;54(2):98-103 – reference: 11121464 - J Natl Cancer Inst. 2000 Dec 20;92(24):2018-23 – reference: 15099940 - Gynecol Oncol. 2004 May;93(2):320-7 – reference: 17172431 - Mol Cancer Ther. 2006 Dec;5(12):3275-84 – reference: 18760546 - Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):935-40 – reference: 9197929 - Biol Trace Elem Res. 1997 Mar;56(3):331-41 – reference: 19602434 - Toxicol In Vitro. 2009 Dec;23(8):1497-503 – reference: 16489034 - Cancer Res. 2006 Feb 15;66(4):2296-304 – reference: 8971064 - JAMA. 1996 Dec 25;276(24):1957-63 – reference: 15213714 - Br J Cancer. 2004 Jul 19;91(2):195-9 – reference: 14713851 - J Urol. 2004 Feb;171(2 Pt 1):907-10 – reference: 10912582 - Cancer Chemother Pharmacol. 2000;46(1):74-8 – reference: 15150444 - Exp Mol Med. 2004 Apr 30;36(2):157-64 – reference: 19351748 - Clin Cancer Res. 2009 Apr 15;15(8):2695-702 – reference: 19641174 - J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205 – reference: 16552729 - J Cell Biochem. 2006 Aug 15;98(6):1495-506 – reference: 17394769 - J Biochem Mol Biol. 2007 Mar 31;40(2):196-204 – reference: 16574336 - Med Hypotheses. 2006;67(2):318-22 – reference: 15073137 - Clin Cancer Res. 2004 Apr 1;10(7):2561-9 – reference: 15037203 - Biochem Pharmacol. 2004 Feb 1;67(3):513-22 – reference: 14748935 - Br J Nutr. 2004 Jan;91(1):11-28 |
SSID | ssj0067082 |
Score | 1.9576377 |
Snippet | Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere... Objective: Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to... |
SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 190 |
SubjectTerms | Original 산부인과학 |
Title | The effects of selenium on tumor growth in epithelial ovarian carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22808362 https://www.proquest.com/docview/1027041208 https://pubmed.ncbi.nlm.nih.gov/PMC3395015 http://synapse.koreamed.org/Synapse/Data/PDFData/1114JGO/jgo-23-190.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001681468 |
UnpaywallVersion | publishedVersion |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Gynecologic Oncology, 2012, 23(3), , pp.190-196 |
journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2005-0399 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067082 issn: 2005-0399 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2005-0399 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067082 issn: 2005-0399 databaseCode: ABDBF dateStart: 20111201 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2005-0399 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067082 issn: 2005-0399 databaseCode: DIK dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2005-0399 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067082 issn: 2005-0399 databaseCode: 5-W dateStart: 20080101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2005-0399 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067082 issn: 2005-0399 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELe2TgJexjcLH5OReAIlTWzn63FidGPSxiSoNJ4sx3HW0taJ2gQ0_nrukrTaNARCPCVxLrZsn-2fc-ffEfLG12EcpEXgKq21K0xSuGmSGzePdZ4nPDGhwQPOp2fR8VicXIQXW2QdjHN1ZVW1Mt6sBMgEy0Fry__cJQ4PVa2G54ej9gpjVJwcfRp-uyxdxl1Y17wqL7bJToSWpgHZGZ-dH3zF0HLItenzNoZaf5-mnX0TEhlmgB5ezGPc416Ak_O1FWrbLovfgc_bPpR3G1upqx9qPr-2QI3uk8n6mE_nlzLzmjrz9M_brI__W_cHZLcHsfSg07qHZMvYR-TOaW-mf0yOQPlo7ylCy4JiRCc7bRa0tLRuFuWSXsLuv57QqaWmwlMhcxgGtPwOG3dlqcb4RrZcqCdkPPrw5f2x20dscLXgrHYNzB4iicIsDgtlDIOZVok4MlkoTAZYKgM4mqSZjxz0Oo_COI8KlYkgSZHpS-X8KRnY0po9QlMRM8FVyHQOIC8wGTNFrgPIK44jlYUO8de9JHVPZ45RNeYStjXYsRJaR2LHSsYll9BIDnm7-aTquDz-JPwaul7O9FQiAzdeQWS2lLDP-Ci5iESAMmvFkDAq0dSirCmbFWTLYmQy8xOHPOsUZVMkEhAlgBscEt9QoY0AlnfzjZ1OWuZvztMQ8JtD3m2U7e81ef5P0i_IPXzuPJJfkkG9bMwrwF11tt_-r9jvR9Yv59wqog |
linkProvider | Unpaywall |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELe2TgJexuegfMlIPIGSJrbz9TgxujFpYxJUGk-WYztraetEbTI0_nrumrTaNARCPDlxLrZsn-2fdeffEfI20FESZkXoKa21J2xaeFlqrGcSbUzKUxtZvOB8chofjcTxeXS-RdbBOJdXTlVL609LgEywHaxs-V_azMGBqtXg7GC4SmGOiuPDz4PvF6XHuAf7ml-ZYpvsxGhp6pGd0enZ_jcMLYdcmwFfxVDrnrOstW9CJsMC0MOL-Yz73A9xcb62Q227RfE78Hnbh_Ju4yp19UPNZtc2qOF9Ml5f82n9UqZ-U-e-_nmb9fF_2_6A7HYglu63WveQbFn3iNw56cz0j8khKB_tPEVoWVCM6OQmzZyWjtbNvFzQCzj912M6cdRWeCtkBtOAlpdwcFeOaoxv5Mq5ekJGw49fPxx5XcQGTwvOas_C6iHSOMqTqFDWMlhplUhim0fC5oClcoCjaZYHyEGvTRwlJi5ULsI0Q6YvZfge6bnS2WeEZiJhgquIaQMgL7Q5s4XRIZSVJLHKoz4J1qMkdUdnjlE1ZhKONTiwEnpH4sBKxiWX0El98m7zS9VyefxJ-A0MvZzqiUQGbkxBZLqQcM74JLmIRYgya8WQMCvR1KKcLZslFMsSZDIL0j552irKpkokIEoBN_RJckOFNgJY380vbjJeMX9znkWA3_rk_UbZ_t6S5_8k_YLcw_fWI_kl6dWLxr4C3FXnr7s59QvtzCmt |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+selenium+on+tumor+growth+in+epithelial+ovarian+carcinoma&rft.jtitle=Journal+of+gynecologic+oncology&rft.au=Park%2C+Jin+Sun&rft.au=Ryu%2C+Ji+Yoon&rft.au=Jeon%2C+Hye-Kyung&rft.au=Cho%2C+Young+Jae&rft.date=2012-07-01&rft.eissn=2005-0399&rft.volume=23&rft.issue=3&rft.spage=190&rft_id=info:doi/10.3802%2Fjgo.2012.23.3.190&rft_id=info%3Apmid%2F22808362&rft.externalDocID=22808362 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-0380&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-0380&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-0380&client=summon |